Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE2651.70104.1 (+4.09 %)

PREV CLOSE ( ) 2547.60

OPEN PRICE ( ) 2544.80

BID PRICE (QTY) 2651.80 (1)

OFFER PRICE (QTY) 2665.25 (1)

VOLUME 966

TODAY'S LOW / HIGH ( )2540.00 2689.75

52 WK LOW / HIGH ( )1411 2822.5

NSE2661.80112.85 (+4.43 %)

PREV CLOSE( ) 2548.95

OPEN PRICE ( ) 2578.85

BID PRICE (QTY) 2648.90 (1)

OFFER PRICE (QTY) 2653.60 (1)

VOLUME 10710

TODAY'S LOW / HIGH( ) 2540.05 2698.00

52 WK LOW / HIGH ( )1400 2823.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981

Management Info

- Chairman Rahul J Nachane - Managing Director

Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE, NSE

NEWS

19Mar Appointment of Director
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..

19Mar Notice of Postal Ballot
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..

19Mar NGL Fine-Chem submits postal ballot no
With reference to its earlier announcement dated March 18, 2024, wherein..

11Mar NGL Fine-Chem informs about board meet
NGL Fine-Chem has informed that the fifth Board Meeting for the financia..

11Mar Appointment of Director
Inter alia to consider and approve: (1) Appointment of Mr. Dhananjay Mu..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	88.96	201.19
Gross Profit	127.96	266
Operating Profit	151.38	356.96
Net Sales	848.12	2750.52

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE) 8660.00 (4.04%)	M.Cap ( in Cr)19893.85
Abbott India (BSE) 26702.30 (1.08%)	M.Cap ( in Cr)56697.60
Dr. Reddy's Lab (BSE) 6270.75 (1.06%)	M.Cap ( in Cr)104511.64
Pfizer (BSE) 4308.75 (1.30%)	M.Cap ( in Cr)19690.28
Hester Biosciences (BSE) 1699.05 (3.21%)	M.Cap ( in Cr)1445.44

Shareholding Pattern

	PROMOTERS	72.74%
	NON-INSTITUTION	27.16%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal S&P B...	0.03

Risk Disclosures on Derivatives

Smart Quotes

NGL FINE-CHEM LTD.